Could your own fat cells ease hip arthritis pain?
NCT ID NCT02844764
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether injecting a patient's own stem cells (from fat) and platelet-rich plasma into the hip joint can reduce pain and inflammation from osteoarthritis. The trial starts with 50 people and plans to expand to 4,000. Researchers will measure pain, quality of life, and look for cartilage regrowth on MRI.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- StroMed (a patient's own stem cells from fat) and platelet-rich plasma (PRP)
- What this could lead to
- If it works, this could offer a way to manage hip osteoarthritis pain and possibly regrow cartilage without surgery.
- What could go wrong
- This is an early phase 2 study with only 50 initial patients, so results are not yet proven. The treatment involves injections, which carry risks like infection or pain at the injection site.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VivaTech International, Inc.
RECRUITINGGrove City, Pennsylvania, 16127, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can discarded bone reveal the secrets to stronger bones?
- Can a new shoulder implant restore Pain-Free movement?
- Can a less invasive hip surgery speed up recovery?
- Which hip implant lasts longer? a Head-to-Head trial aims to find out
- Ear cartilage to the rescue? a tiny biopsy could rebuild knees
- Which nerve drug wins the battle against Post-Surgical knee pain?